- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 253.88M sh |
| Shares Diluted | Q1 2026 · Mar 28, 2026 | 256.87M sh |
| Shares Diluted | Q1 2026 · Mar 29, 2025 | 261.57M sh |
| Stock Repurchased | Q1 2026 · Mar 28, 2026 | $16.6M |
| Stock Repurchased | Q1 2026 · Mar 29, 2025 | $13M |
| Capex | Q1 2026 · Mar 28, 2026 | $16.7M |
| Capex | Q1 2026 · Mar 29, 2025 | $17.5M |
| Operating Cash Flow | Q1 2026 · Mar 28, 2026 | $30.2M |
| Operating Cash Flow | Q1 2026 · Mar 29, 2025 | $7.3M |
| Long Term Debt | Q1 2026 · Mar 28, 2026 | $2.2B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.2B |
| Short Term Debt | Q1 2026 · Mar 28, 2026 | $30.9M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $36.2M |
| Cash And Equivalents | Q1 2026 · Mar 28, 2026 | $785.3M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $812.1M |
| Stockholders Equity | Q1 2026 · Mar 28, 2026 | $3.37B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.33B |
| Current Liabilities | Q1 2026 · Mar 28, 2026 | $678.5M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $735.4M |
| Total Liabilities | Q1 2026 · Mar 28, 2026 | $3.39B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.46B |
| Current Assets | Q1 2026 · Mar 28, 2026 | $2.49B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.48B |
| Total Assets | Q1 2026 · Mar 28, 2026 | $7.12B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.15B |
| Eps Diluted | Q1 2026 · Mar 28, 2026 | $0.23 |
| Eps Diluted | Q1 2026 · Mar 29, 2025 | $0.24 |
| Eps Basic | Q1 2026 · Mar 28, 2026 | $0.24 |
| Eps Basic | Q1 2026 · Mar 29, 2025 | $0.24 |
| Sga Expense | Q1 2026 · Mar 28, 2026 | $226.9M |
| Sga Expense restated | Q1 2026 · Mar 29, 2025 | $216.2M |
| Net Income | Q1 2026 · Mar 28, 2026 | $59.7M |
| Net Income | Q1 2026 · Mar 29, 2025 | $62M |
| Operating Income | Q1 2026 · Mar 28, 2026 | $109.9M |
| Operating Income restated | Q1 2026 · Mar 29, 2025 | $125.8M |
| Gross Profit | Q1 2026 · Mar 28, 2026 | $338M |
| Gross Profit | Q1 2026 · Mar 29, 2025 | $344.6M |
| Cost Of Revenue | Q1 2026 · Mar 28, 2026 | $513.1M |
| Cost Of Revenue | Q1 2026 · Mar 29, 2025 | $503M |
| Revenue | Q1 2026 · Mar 28, 2026 | $851.1M |
| Revenue | Q1 2026 · Mar 29, 2025 | $847.6M |